Quantitative Morphometric Response to Neoadjuvant Androgen-Deprivation Therapy and Its Prognostic Role After Radical Prostatectomy. [PDF]
Afanasiev Y +5 more
europepmc +1 more source
Glucagon-like peptide-1 receptor agonist versus other anti-diabetic agents on patients with prostate cancer undergoing androgen-deprivation therapy. [PDF]
Huang SC +5 more
europepmc +1 more source
Post-SABR early PSA density kinetics in androgen deprivation therapy-naïve patients: early landmark models for long-term biochemical recurrence-free survival. [PDF]
Greco C +8 more
europepmc +1 more source
Radiofrequency Echographic Multi-Spectrometry for bone health assessment in prostate cancer patients receiving Androgen deprivation therapy: A prospective comparative observational study. [PDF]
Montatore M +6 more
europepmc +1 more source
Central and peripheral areal BMD, bone microarchitecture, and strength after initiation of androgen deprivation therapy in men with prostate cancer: a two-year follow-up study. [PDF]
van Oostwaard MM +4 more
europepmc +1 more source
Impact of Androgen Deprivation Therapy on Lower Urinary Tract Symptoms in Patients with Prostate Cancer. [PDF]
Park TY, Shim SR, Kim CH.
europepmc +1 more source
Risk Factors for Hot Flashes Associated with Androgen Deprivation Therapy in Japanese Patients with Prostate Cancer. [PDF]
Sawada M +4 more
europepmc +1 more source
Short-term clinical outcomes of cytoreductive radical prostatectomy combined with abiraterone-based androgen deprivation therapy in oligometastatic prostate cancer. [PDF]
Li B +8 more
europepmc +1 more source

